New FDA draft guidance for drugmakers focuses on trial design for developing obesity treatments. Read more here.

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, making it the first medication for certain patients with the condition.

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on Medicaid and have become yo-yo dieters who, despite their best efforts at changing their eating habits and lifestyles,

McGill University researchers say their study has found GLP-1 drugs are safe and effective for treating obesity and overweight adults without diabetes. The authors say the findings support using the medication to treat those who are overweight and obese among otherwise healthy patients.

It’s January, which is typically when many of us are looking into shedding some pounds. We’ve been hearing a lot about how weight loss drugs are impacting weight loss. Dr. Joseph St. Pierre with Hartford HealthCare Digestive Health Institute joined Good Morning Connecticut at 9 a.